Profile
Nancy Vitale is identified in SEC filings as a director of Voyager Therapeutics, Inc., a biotechnology company focused on gene therapies for neurological diseases. Based on the 2026-06-11 SEC filing context, she serves as a director of Voyager Therapeutics. Public information about her broader career, education, or other board roles is not provided in the context available. Her notability appears to derive primarily from her role on the Voyager Therapeutics board rather than widespread public prominence.
| Role | Director |
|---|
| Notability | 20/100 |
|---|
Board memberships
- Voyager Therapeutics, Inc.
Awards & honors
- Director, Voyager Therapeutics, Inc. (as of 2026)
Frequently Asked Questions
Who is Vitale Nancy?
Nancy Vitale is identified in SEC filings as a director of Voyager Therapeutics, Inc., a biotechnology company focused on gene therapies for neurological diseases. Based on the 2026-06-11 SEC filing context, she serves as a director of Voyager Therapeutics. Public information about her broader career, education, or other board roles is not provided in the context available. Her…
How many SEC Form 4 filings has Vitale Nancy submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Vitale Nancy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.